The year-end dividend forecast for the fiscal year ending March 2026 was revised upward by 5 yen per share to 38 yen, with the annual dividend reaching 71 yen, marking the 14th consecutive increase.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4507","jir_company_name":"Shionogi & Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-04-27","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/04\/4507-20260427-01.pdf","jir_short_summary":"The year-end dividend forecast for the fiscal year ending March 2026 was revised upward by 5 yen per share to 38 yen, with the annual dividend reaching 71 yen, marking the 14th consecutive increase.","jir_summary":"### Details of Dividend Forecast Revision\nShionogi & Co., Ltd. has revised its year-end dividend forecast for the fiscal year ending March 2026 from 33 yen per share to 38 yen, a 5 yen increase, and adjusted the annual dividend forecast to 71 yen. This marks the 14th consecutive dividend increase. The amounts are stated on a post-stock split (1:3) basis and form part of the dividend policy under the medium-term management plan STS2030 Revision, which aims for a dividend on equity (DOE) of 4% or higher.\n\n### Background of the Dividend Increase and Outlook\nThe dividend increase is backed by growth in the HIV business, domestic and overseas business investments, and business foundation strengthening through M&A, contributing to the expansion of the earnings base. Especially, the penetration of long-acting injectable formulations in the HIV field and progress in new drug development contribute to earnings stability. Based on these factors, the company aims to maximize corporate value and optimize shareholder returns, striving for stable dividend growth.","jir_financial_highlights":"Year-end Dividend Forecast: 38.00 yen (Increase of 5 yen from previous forecast)\nAnnual Dividend Forecast: 71.00 yen (Increase of 10 yen from last fiscal year's 61.00 yen)\nInterim Dividend Actual: 33.00 yen (Unknown)","jir_category":"","jir_hashtags":"#Shionogi, #DividendIncrease, #JapanStocks","jir_key_figures":"Year-end Dividend Forecast: 38.00 yen (increase of 5 yen from previous forecast)\nAnnual Dividend Forecast: 71.00 yen (increase of 10 yen from last fiscal year's 61.00 yen)\n14th consecutive dividend increase planned","jir_meta_title":"Shionogi Increases Dividend to 71 Yen\uff5cFY March 2026","jir_meta_description":"Shionogi revised its year-end dividend forecast to 38 yen for the fiscal year ending March 2026, with an annual dividend of 71 yen marking the 14th consecutive increase, supported by growth in the HIV business and strengthened business foundation.","jir_og_title":"Shionogi Increases Dividend to 71 Yen\uff5cFY March 2026","jir_og_description":"Shionogi increases its dividend forecast for the fiscal year ending March 2026. With an annual dividend of 71 yen and 14 consecutive increases, the company aims for stable shareholder returns.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":6919,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"dividend","footnotes":""},"sector":[],"importance":[],"class_list":["post-42702","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n